From ddf76332bdb7b846f2082a1aa0934f265f612c9d Mon Sep 17 00:00:00 2001
From: Benedikt Venn <venn@bio.uni-kl.de>
Date: Mon, 22 May 2023 15:22:45 +0200
Subject: [PATCH] update readme

---
 .gitattributes  |   1 +
 .vs/slnx.sqlite | Bin 0 -> 90112 bytes
 README.md       |  24 ++++++++++++++++++++++++
 3 files changed, 25 insertions(+)
 create mode 100644 .gitattributes
 create mode 100644 .vs/slnx.sqlite

diff --git a/.gitattributes b/.gitattributes
new file mode 100644
index 0000000..2635f9c
--- /dev/null
+++ b/.gitattributes
@@ -0,0 +1 @@
+**/dataset/** filter=lfs diff=lfs merge=lfs -text
diff --git a/.vs/slnx.sqlite b/.vs/slnx.sqlite
new file mode 100644
index 0000000000000000000000000000000000000000..168fd5ce43f51685181fce57293ddad9be97751e
GIT binary patch
literal 90112
zcmeI4TWlLwdVpt0iWDhwj_$Nf%bK7;BGw++qVDUaSehEyj44VYDLbyp5<_xiPfd{y
zIkGJvKq0#ubQ7$L0DWi|3$%UN-G@H(_D~eqqA0d4+Lso)L4hJb3+yh?MbXQqDB1>T
zfu1unXKo}#t(?lW^Ape!&-~}|pYQztKWEMvDZiCbRGHsxH1{NxpJN6YmSw)k^9;lE
z;h%B*Lq8+<i;rgTZ`Ss`+t)s3W@nBx#G+40nPK#4_?zLufg7Qx!T0+=3V8in-VZ#V
zcygXMyEOsVUl;=YMAO4pxj^)mz#eWX^{V_Rf3R0>)K=wPrLL$-qh8X#*6*w-H91`^
zr8^ZushpTBh<rM`D!#?<9IK6DB*f#-Mz+0tk)Pgic3X@ejzt2|6jt+EXEn3Zp4?eE
zu7`3~%^oU|f<->Hk;#y;W;asFycqw|8{t4y5ZLzwRVvqH_t4$>h@ng&c{L+;7<nW#
zt#fIEn64Hv--38e%<-GK^m;OPo4+C6=9AlnjdT__yDnx6SS$RqoylA@TG?zi9w=40
zX|GMo=tamR<is^GCuUP(p5LK0#JZ}e2gPag0&XI1Rl)PNy}3$2U<|3`s^}1{iW$)o
zQDt<1*_+8+>UuIaomg0in+m(Q(kg5Fwc5efzEo3o6}j4}0q1<sdN;6@SiI<nsWe%s
z$gP%AR%&F3CRTSbmkqX+vxaO3NE{`9&{E|+6QTPOLCIUSPr@?Os7S;=bB%}H2S5v@
z8nyksdV9G@D1LZpAP_BKzba{drD<A`>UFu9k}7xQQoHK9m$?guonGb^cWuY!bM89W
z_S$<d#-D75G>?0?sCk^bmODS-^f<Q|_fI{}EwcN}F+9$g&`vtHS&qZww0?UV%(K}G
zb!+>esJ%P1p#@Fjr5D=#zq6AU4({V9Nh1~Qf_h#-*^^tUw0FPAli*QEuj5FH;}x+)
zAsC2WinEWAW{I?0(q4%q^n$Kf$e7mcY<g?kyz|g9W+j_>QJFC?e2<}5bd_C!#FXBY
zn=R~UZIS;m(;tY&<Lr|wnjO-{^yZzppwkAOLYoCrfqjyWVR^b`m<sE|vBK=-o>7+e
zYYz1|mC2NSArOd)0-Z9qA(u9#rd(G`By787{T=7eUCQ2qZ7SWx$bzBM-T5NEooOn#
zD-c^gyy_1`@8QUIU`0Ng7aCo+*R;hyTk(J~9%BjQuGXWq9%DOV5MzDzWl>wVgi2?H
z{XG=6YW7gB6ZrU(>pne5r>r1tqvh7K&*>m;vCT!?qLaCbuCrz3$5@GUodYY@X>p9K
zr^x37OM+*M@aYy|Q{=Cv+n0eEsikg|TXOS(jF&}L<TX}{{HnN?+|CsE%6?PxSe1rp
z?Boq^AUYdk52rLY$;+y$)bD6MZLGKTD?X<^wU^V(NL%jf6}mZXeADBPUbw*C)-0#>
zHeRF2rI!5mzFfzvHfPrBup5_fx{i(iBCZ)fyv7Eiu^9VU*4i|5Gk$p-ZR{9VZ6;@2
zIW<eWDb@DzJi4rN8$YWJg(5ihavw72hulBmU+@6}KmZ5;0U!VbfB+Bx0zd!=00AKI
z!Vnnu`j|^7O%4|EMkG0zNj3KC>g?fxr;oYv<Qmz$(4_idT3$b%XwAuT<?>>pBFxS&
z&I$8N%a;Xdu2L1`#f4e<^2)-}qKq$>=Mt60<s~7pJX;awD~nY@N=UQ9Ty=SAzPu|X
zs`FK0sXSM%E>!1)<+;U#FrQee3d<|fys$K%*iFcZ#KK}FAygI<%Zp2uim<pOEerE2
zl|?~Xsa_TmWqEgQaizLk-dz%^D~Z`eWuYppEG<a5kc<m0EzAjt-G$}F@@{$e@)9nz
zTUlCInOzZ<s}k<6JYNyY)%gWsc5$JaC|7nDcNb^JSs(LyG>=bU_9SChc6MfNW+8(9
zp7EgXFz7qzA77XW21S7Y5C8%|00;m9AOHk_01yBIKmZ7Q?g<RA-WY4VV&KIz27>x4
zE~6f=z`Ead;X}BD7k!IC-$LI-|N6Oy2LONo5C8%|00;m9AOHk_01yBIKmZ8*|06Kw
zy~MV?=HQKaudrQSaqtX!Uk^H70wC}I^WooS&_AQUMSqIEfxdzsqAj$HUPTe^-?@*t
zKjFT?{W5o-yUG0&_Y+(w@^R#EB43L<iQJ8(BbOp$;ZMWg3;zXf06stf2mk>f00e*l
z5C8%|00;nq&zL}z_cN1h&_8oWQSZs}{ek|Ee&)|ET)z^EPB{gWrr^9&5Tk-KlYVB3
z?e{n3R%5@3UlX4&CFh7F=*RzrYIR+l*{fQTm|o|8v!OOBjha<w@~oeU<2p)9nrW%~
z)q|NwwbmoE;>3iXc?EZdUr1Nw#-37Xg=lZlGfo9f!E)5klyH+*8;yIjrMz5e%4!4u
z`-Q@_wbI5TsZ?v+N#w{s?J0>(t+#R7<ixnUw;&Zo$DF-cf>Ebn$gDBq6d)=%Gwi~|
znUWzFCQ~vwXkn6CElI~@ipP<kiD67tNtIf%YF?k<+ynB{zM>JQdX^yU6nM-U16Vtz
z-~X`Dyti9xJZw?HSP1uy1!Vpd*}Oa)^fP1la&y0KUW@jVHf$zB+juqLXI8L)*nv`i
zfd4s-a!32eO4<z3Qlox9Gl84b5SWdg>BFPMb%}8+cj}F%Ov|71VQhv(Qq`tX-dAl3
zdUXX!Jz8VfV_cJ(6?$!m^)n;5*O>=qm*o7P=U!vbkI+A$5AhCwgbLjMa6jU{&;1(r
zMQ)CJ4Sj<Cko!7XL9d}-=N=-F`;dDNo#7Pp0Sa+D+&cOt^bV?j#%>PH0RbQY1b_e#
z00KY&2mk>f00e-*b0HA+PO@~zg|}y>?3wcs?-Xn9rc9EYxr1_!<jh@@*swRwI(JIW
za^6>1Yj<SA-tZa0TVjvB3lep<G;VKc%$^ywXGR?A4m;ExqUu^Z7J~!$Eqh~^0y#V6
z?9E2(nJ{V9+;tcrO&D7Zp?>ceOZFFn4mJAEdRH_~?K=s9kavRBw-5ZJe{0X6k7!G>
z)<%JkG*2#hwJ&%}z~lFh1o1wA_WX}B4Ek^MpXlH4TL3>q-$#Fk-v#&({T2F4^lkJ<
z=nv3S?HT_8%AnsxzlFYzegl0K{R(=F?xUYaRrGV{EtGpMW(l1F0U!VbfB+Bx0zd!=
z00AHX1b_e#cn$>myevDwlXP;5q_OiPotV_pb6OhH(z7HDO=#&El8#478XVWsF_I3A
zk`#@QlpEI4AuS!$QbbZer=<~+dcr<0!w!%nM3Nv$`biQXiJv5WB=M2NOA?RQ%LKLO
z|H#J-`WN&A^w;Q*Q30Ruf16VyA9LU1zRMwwLH~t*pL>E&|A)}8a#=Lb{T^3AEcess
z%iPD@40j&=0&1elbHEK<0s$ZZ1b_e#00KY&2mk>f00e-*Q3N>OBx|1K5Acrc<dh>D
zJCA%*taYM4F{$OvGyREkTHZX>pNNh6;;idjf8y+*?-kZ|vLBjobP_sq$yZ{Jf4V;&
zb+s29ceEEAb7Y4`9a%Ku90E7&90E6F4#7I>=LRFb7)ww4Ipk8n&pEpAM;uvCnDb3B
zwp0JGFUFY1{z2auqo4b0rA)N_G2aT)?c{&JH^I=Of8=|Gv7h~q_~LrrcKEM#qMiQh
z-^lTQz&FB>^MCU9|IFY~1_Lr600e*l5C8%|00;m9AOHk_01yBIK;T6uK+gZ+`Ts?q
zMbIAz00AHX1b_e#00KY&2mk>f00e-*(FEZ9|7boS1p+_-2mk>f00e*l5C8%|00;m9
zAn-B}fb;*CVHRNwKmZ5;0U!VbfB+Bx0zd!=00AHX1db*E=l@6Z0Vxmw0zd!=00AHX
z1b_e#00KY&2mpbXfdHKUzYMboV*mm`00;m9AOHk_01yBIKmZ5;0U&TR0eJpDnh!{U
z01yBIKmZ5;0U!VbfB+Bx0zd!=ybJ{3{r{I?7GVrP00;m9AOHk_01yBIKmZ5;0U!Vb
zjwV2!|3d*UgBH0TaINq+!-E4iLQjM5_kR@d`nS9vcs}vuJZ~P|21tQ`oq+FmqPGP0
za7(FI<wyC0y>g?rD(@<FMO7O0lK!=RXHBWe>1rw6sSrx##AHF_)7e$=Eq>=%Z4@IR
z9)C8n?d6O7^p3OJV*GF{5{Ra-n%6q3nU(hB&dPB;l(TB~P>B>Q@~MqXhKx14kxJ&p
z_?O-Y2cm+&z9*<sxhA`Z?#@RHWeUlw8L`92BcW-XOB=*=wTSr^#A{-X-^``gleydc
z4e>Ug+%9aSv$)xHF<Zb|;h*hH=AzNcX0!1?sme`zZCXYzLM9<6u8BD@n-cT<4y_^9
zRYg50PMa5S6LG5wp11AIRRRKINF`TAhiFyIh?a;dqXW#|Oy*M8ley`{!b03s*u|Ar
zS=+DG4z~8CnzF0N)lLmK=Y!U}fvv>iMMq4f$x20TwUn|_BSSQ?x{JANu&tamWII6O
zDEWhyD({&H-IoYT-l}~PmYGIHBL10cJnTLIS}4`1?eEpw%SA%*!%G8!XbJmON%JdB
z(~4BD%gvNjxht32RoA`DT`=tQGPk&EJ2szl*TJ^e-g`0rWILpJ+`C21<J`5}`2nZL
zxy87D>Tzz7-Di&BamIvp(z(rY93H3j+uLBC&0eTm+XqGM-JuOFXc{lQ(B}W0oxE^x
zA4f?Vsc09}^9stI+)|~z`$e7vk3xDKM^YTGh$RZaK=e|aeT+0qq}`JCN+h8dbj3o(
zv~Fk9TifQHhn6ub+02W|jDg{M485YO><T2N^rqZwVMl9={EwObKr|j_pIp)GkT#|_
z@5}|AHs}=EERYK9lXMKr(=EePSRalRW-s@Qvb0}wsK=>HrtAxWKvWdyl(`MLv?(>^
zx>_P(+b!$wIDhU^_7-eY=`KbV44v-I7xC>(Q^8$<*z)03e;|4fN4^6q^4Yx5=(@e8
zE&kbx2aNF;OCWc(9<B8l+Yy5p>$5M5+PWoFIxFn&p|Dl6hjN|3$DdsH=|MVW1!)^C
zx1N1Y2XTvSF5(uQ%vE%qEh|69N~G%?Sg}rvV`M!=J||cbJX?fMw+Ndee>L5{49rL^
zb)(#pn-65XEV3f6v0CI;#kJ&irodPBo0`X}G)!YBZ+HXI*%*5`rMXF7R#l~bNAqc8
zy{%vIIqj*voMuMaa$m2|&1vJC9)I-01@^XPIjy(x8ci;><hS?bI$pIovtEbYxP;Sn
zZ2T8-&G_LpHV}=)*vGQgrlFhh%j0Nc$GB=UIpfNyS=vphwvXr0Wu5v>QhWYqo-!yK
zemd|U0~`Ibfp`3W?#p<86JI>_&%1-8fiXeofB)74MSe)u>YI{!SGxl$a?71JINwZ*
zw|KXVms*j~t#si!_M6mpE}y<BwwFofjinm#uRMOlNEP_@c)%y~{8g#tSc9jl7x``u
zOv<NpyVr~8cW_dLgb9aOz00rVHrCsEwLBNEM>eunR@c(X6U{egI;iI?vX-Cu@zrf>
zLR0^pclg(T_H`cr+MF?miN|3dwR+d8tB=n$m8A5hRVJOy;-}Cz@pESz2~u(`k00x;
z(s(c(X6X&PJ|yT+>^S5^LUeZXGe3FJrFY9Tj7aDxWsjpIR<)aM?Q?_;^g4b_?rbc4
zI<GBc52r^0(VaMZc-ytASd~<%>r;@$hZGxkhEk`nYa1PJ)1)~PXstFV=3@L89}Q~@
z*e_pj-J?k*s{+Z5Ib)<#XbY82!O0?~)rP66b&EA_Se9{};5Pe=Pu_H~Y#$wc%yHcH
zX+eD$NA08>^(1B8270gKPq3^pZZ-w+E$7BjL2BNS)lPSzE;}`;MqQO39j69)a7YZ{
zU57cxu7kEb%*nel4h9vuWPT&|KsO#O+c3qW-JHcN(YdLP?qb%#vt@qQ6~GS+iNRh<
zugdr3dR3~cJ(M2lt#rqxdMfRzRgAwILxJer9Q(d)x5P=h1Jl87?rt*a=<}wu-Eoic
z6ifF{sM~b%ug-o?YxH)sAA8Hv&GWO3MAmRlvIS`3HVo9#?fE{4IP@Y5!Xj^mmoCBM
z|1jE^J5SDiDPzy+RW1OBA8B%?V+$?rLyN9YYH;`ghaV@}>3GH^7(Lhc{2hM4-~XTb
zCI@r~1b_e#00KY&2mk>f00e*l5C8%|;M57g^Z%(MhYo=N5C8%|00;m9AOHk_01yBI
zKmZ7wIsy3qf2WQdIs^hh00;m9AOHk_01yBIKmZ5;0U&Vd1mOJt)R9AnKmZ5;0U!Vb
VfB+Bx0zd!=00AHX1Wuj6{{qpL4@Uq1

literal 0
HcmV?d00001

diff --git a/README.md b/README.md
index 2bb127a..09f76f1 100644
--- a/README.md
+++ b/README.md
@@ -1,6 +1,30 @@
 
 ### Project description
 
+#### Title
+
+The macrocyclic lactone Oxacyclododecindione reduces fibrosis progression
+
+#### Authors
+
+Sabrina Saurin, Myriam Meineck, Markus Rohr, Wilfried Roth, Till Opatz, Gerhard Erkel, Andrea Pautz, Julia Weinmann-Menke
+
+#### Background
+
+Renal fibrosis is one of the most important triggers of chronic kidney disease and only a very limited number of therapeutic options are available to stop fibrosis progression. As fibrosis is characterized by inflammation, myofibroblast activation and extracellular matrix deposition, a drug that is able to address all these processes might be an interesting therapeutic option.
+
+#### Methods
+
+We tested _in vivo_ in an ischemia reperfusion (I/R) model in C57BL/6 mice and in kidney tubular epithelial cells (HK2 cell line and primary cells) and whether the natural product oxacyclododecindione (Oxa) reduces fibrosis progression in kidney disease. This was evaluated by western blot, mRNA expression, and mass spectrometry secretome analyses as well as by immunohistochemistry.
+
+#### Results
+
+Indeed, Oxa blocked expression of epithelial-mesenchymal transition marker proteins, reduced renal damage, immune cell infiltration and collagen expression and deposition, both _in vivo_ and _in vitro_. Remarkebly, the beneficial effects of Oxa were detected also when the natural product was administered at a time point of established fibrotic changes, a situation that is close to the clinical situation. Initial _in vitro_ experiments demonstrated, that a synthetic Oxa derivative possess similar features.
+
+#### Conclusion
+
+Although open questions such as possible side effects need to be investigated, we believe that the combination of anti-inflammatory and anti-fibrotic effects of Oxa make the substance a promising candidate for a new therapeutif approach in fibrosis treatment and therefore the prevention of progression of keidney disease.
+
 ### Sample processing protocol
 
 HK2 cells were stimulated and supernatant prepared as described in the publication. Mass spectrometry analysis was performed on a high-resolution LC-MS system (Eksigent nanoLC 425 coupled to a Triple-TOF 6600, AB Sciex) in information dependent acquisition (IDA) mode. For detailed information, see supplemental methods.
-- 
GitLab